Anti-Olanzapine (Clone OLA-3578)

Leinco Technologies
Product Code: LEI-O500
Product Group: Primary Antibodies
CodeSizePrice
LEI-O500-1.0mg1.0 mg£707.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: Mouse IgG2a κ
Antibody Clonality: Monoclonal
Antibody Clone: OLA-3578
Regulatory Status: RUO
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Lateral-Flow Immunochromatographic Assay
Shipping:
2 - 8°C Wet Ice
Storage:
This purified antibody is stable when stored at 2-8°C. Do not freeze.

Further Information

Concentration:
≥1.0 mg/ml
Formulation:
Formulated in 0.015M potassium phosphate buffered saline (0.85%), pH 7.2 and contains 0.05% sodium azide.
Product Description:
Olanzapine, a second-generation or atypical antipsychotic, is widely used in the management of various mental health disorders, including schizophrenia and bipolar disorder. Introduced in the late 20th century, olanzapine exerts its therapeutic effects by antagonizing multiple neurotransmitter receptors, particularly dopamine and serotonin receptors in the brain. This dual-action helps to modulate the imbalances in these neurotransmitters associated with psychotic disorders. Olanzapine's method of action also involves histamine and alpha-adrenergic receptors blockade, contributing to its efficacy and potential side effects. Diagnostic testing for olanzapine is not standard practice, but periodic monitoring may be considered in specific cases for therapeutic drug monitoring. Blood tests can be utilized to measure olanzapine levels, aiding clinicians in optimizing dosage to achieve optimal symptom control while minimizing adverse effects. This tailored approach to monitoring ensures a personalized and effective treatment strategy for individuals prescribed olanzapine for various psychiatric conditions.
Target:
Olanzapine